AVR 0.00% $18.31 anteris technologies ltd

Listened to the interview again. A third VIV patient was...

  1. 13,916 Posts.
    lightbulb Created with Sketch. 124
    Listened to the interview again. A third VIV patient was recently approved by Health Canada. Missed that little snippet the first time round.

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.